Welch Allyn.(Product Pipeline)
February 01, 2004
|
Ventracor (Sydney, Australia) reported the fourth implant of its Ventr...
February 01, 2004
|
Vasomedical (Westbury, New York) said a study published in the Decembe...
February 01, 2004
|
Tepha.(Product Pipeline)
February 01, 2004
|
Synthetic Blood International.(Product Pipeline)
February 01, 2004
|
St. Jude Medical.(Product Pipeline)
February 01, 2004
|
SS&II.(Product Pipeline)
February 01, 2004
|
MicroMed Technology (Houston, Texas) reported FDA approval of the comp...
February 01, 2004
|
Medtronic.(Product Pipeline)
February 01, 2004
|
Medicsight.(Product Pipeline)
February 01, 2004
|
Guidant.(Product Pipeline)
February 01, 2004
|
Endologix.(Product Pipeline)
February 01, 2004
|
Devax.(Product Pipeline)
February 01, 2004
|
Cardima.(Product Pipeline)
February 01, 2004
|
Boston Scientific.(Product Pipeline)
February 01, 2004
|
Biotronik.(Product Pipeline)
February 01, 2004
|
Biophan Technologies (Rochester, New York), a developer of advanced bi...
February 01, 2004
|
CryoCor begins U.S. trial for atrial flutter.(Product Pipeline)
February 01, 2004
|
VivoMetrics.(Personnel File)
February 01, 2004
|
St. Jude Medical.(Personnel File)
February 01, 2004
|
Serologicals.(Personnel File)
February 01, 2004
|
Omnisonics Medical Technologies.(Personnel File)
February 01, 2004
|
LifeWave.(Personnel File)
February 01, 2004
|
Therapeutic cloning aids in heart cell repair.(Market Updates)
February 01, 2004
|
GenVec (Gaithersburg, Maryland) said it has entered into a research co...
February 01, 2004
|
Cardiac Science (Irvine, California), a manufacturer of automated defi...
February 01, 2004
|
Biophan Technologies (Rochester, New York), a developer and marketer o...
February 01, 2004
|
Study eyes adipose regenerative cell use.(Business Developments)
February 01, 2004
|
Recom Managed Systems (Los Angeles, California) reported that it would...
February 01, 2004
|
Charles River Laboratories International (Wilmington, Massachusetts) h...
February 01, 2004
|
Irish biomed center gets EUR 19M for studies.(Report from Europe)
February 01, 2004
|
Cytokine IL-6 plays role in heart damage from septic shock.(From the L...
February 01, 2004
|
Investors hear companies and clinicians discuss opportunities.
February 01, 2004
|
Xtrak Medical.(Product Pipeline)
February 01, 2004
|
WorldHeart (Ottawa, Ontario) reported that the FDA has approved its pr...
February 01, 2004
|
